COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 1841: Articles 18401-18410  | Next

Characterization of SARS-CoV-2 genetic structure and infection clusters in a large German city based on integrated genomic surveillance, outbreak analysis, and contact tracing
Walker, A., Houwaart, T., Finzer, P., Ehlkes, L., Tyshaieva, A., Damagnez, M., Strelow, D., Duplessis, A., Nicolai, J., Wienemann, T., Tamayo, T., Kohns Vasconcelos, M., Hülse, L., Hoffmann, K., Lübke, N., Hauka, S., Andree, M., Däumer, M. P., Thielen, A., Kolbe-Busch, S., Göbels, K., Zotz, R., Pfeffer, K., Timm, J., Dilthey, A. T., German COVID-19 OMICS Initiative (DeCOI)
10.1101/2021.02.13.21251678 — Posted: 2021-02-18
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with build-in screening functionality for DelHV69/70- and N501Y variants such as B.1.1.7
Nörz, D., Grunwald, M., Olearo, F., Fischer, N., Aepfelbacher, M., Pfefferle, S., Lütgehetmann, M.
10.1101/2021.02.12.21251614 — Posted: 2021-02-18
Potent neutralization antibodies induced by a recombinant trimeric Spike protein vaccine candidate containing PIKA adjuvant for COVID-19
Tong, J., Zhu, C., Lai, H., Feng, C., Zhou, D.
10.1101/2021.02.17.431647 — Posted: 2021-02-17
Traditional use of Cissampelos pareira L. for hormone disorder and fever provides molecular links of ESR1 modulation to viral inhibition
Haider, M., Dholakia, D., Panwar, A., Garg, P., Anand, V., Gheware, A. P., Singhal, K., Singh, D., Burse, S. A., Enayathullah, M. G., Parekh, Y., Ram, S., Kumari, S., Kumar, A., Ray, A., Medigeshi, G. R., Bokara, K. K., Sharma, U., Prasher, B., Mukerji, M.
10.1101/2021.02.17.431579 — Posted: 2021-02-17
Phase transitions may explain why SARS-CoV-2 spreads so fast and why new variants are spreading faster
Phillips, J. C., Moret, M., Zebende, G. F., Chow, C. C.
10.1101/2021.02.16.431437 — Posted: 2021-02-17 Discussion: Offsite
How the replication and transcription complex of SARS-CoV-2 functions in leader-to-body fusion
Li, X., Zhao, Q., Chang, J., Duan, G., Bei, J., Yau, T. O., Yang, J., Ruan, J., He, B., Shan, G.
10.1101/2021.02.17.431652 — Posted: 2021-02-17
Multiple Sites on SARS-CoV-2 Spike Protein are Susceptible to Proteolysis by Cathepsins B, K, L, S, and V
Bollavaram, K., Leeman, T., Kulkarni, A., Upshaw, S., Lee, M., Yang, J., Song, H., Platt, M. O.
10.1101/2021.02.17.431617 — Posted: 2021-02-17
A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
Fatihi, S., Rathore, S., Pathak, A., Gahlot, D., Mukerji, M., Jatana, N., Thukral, L.
10.1101/2021.02.17.431625 — Posted: 2021-02-17 Discussion: Offsite
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Yuan, M., Huang, D., Lee, C.-C. D., Wu, N. C., Jackson, A. M., Zhu, X., Liu, H., Peng, L., van Gils, M. J., Sanders, R. W., Burton, D. R., Reincke, S. M., Prüss, H., Kreye, J., Nemazee, D., Ward, A. B., Wilson, I. A.
10.1101/2021.02.16.430500 — Posted: 2021-02-17 Discussion: Onsite
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys
Saunders, K. O., Lee, E., Parks, R., Martinez, D. R., Li, D., Chen, H., Edwards, R. J., Gobeil, S. M. C., Barr, M., Mansouri, K., Alam, S. M., Sutherland, L. L., Cai, F., Sanzone, A., Berry, M., Manne, K., Kapingidza, A. B., Azoitei, M., Tse, L. V., Scobey, T. D., Spreng, R., Rountree, R. W., DeMarco, C. T., Denny, T. N., Woods, C. W., Petzold, E. W., Oguin, T. H., Sempowski, G. D., Gagne, M., Douek, D. C., Tomai, M. A., Fox, C. B., Seder, R., Wiehe, K., Weissman, D., Pardi, N., Acharya, P., Andersen, H., Lewis, M. G., Moore, I. N., Montefiori, D. C., Baric, R. S., Haynes, B. F.
10.1101/2021.02.17.431492 — Posted: 2021-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).